Fisher & Paykel Healthcare (FSPKF) Raised to “Neutral” at Goldman Sachs Group

Goldman Sachs Group upgraded shares of Fisher & Paykel Healthcare (OTCMKTS:FSPKF) from a sell rating to a neutral rating in a report issued on Thursday morning, The Fly reports.

Shares of OTCMKTS:FSPKF remained flat at $$9.21 during midday trading on Thursday.

About Fisher & Paykel Healthcare

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, and markets medical device products and systems worldwide. The company offers its products for use in respiratory, acute care, and surgery; and for the treatment of obstructive sleep apnea (OSA).

Recommended Story: What are the Benefits of Index Funds?

The Fly

Receive News & Ratings for Fisher & Paykel Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fisher & Paykel Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.



Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit